索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]商鲁翔 冯敏 汤宝鹏.隐匿性心房颤动筛查的研究进展[J].国际心血管病杂志,2019,03:129-133.
点击复制

隐匿性心房颤动筛查的研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2019年03期
页码:
129-133
栏目:
综述
出版日期:
2019-05-27

文章信息/Info

Title:
-
作者:
商鲁翔 冯敏 汤宝鹏
830054 乌鲁木齐,新疆医科大学第一附属医院起搏电生理科
Author(s):
-
关键词:
心房颤动;  隐匿性心房颤动;  卒中;  筛查
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2019.03.001
文献标识码:
-
摘要:
隐匿性心房颤动(房颤)是指无典型临床症状、无确切房颤病史,但可通过心电监测技术检出的房颤。隐匿性房颤占总体房颤的15%～40%,对隐匿性房颤患者进行筛查、确诊和治疗,可有效降低致残率和致死率,显著降低医疗成本,节约医疗资源。该文主要介绍隐匿性房颤筛查的重点人群、筛查策略及筛查方式。
Abstract:
-

参考文献/References

[1] Staerk L, Sherer JA, Ko D, et al. Atrial fibrillation epidemiology, pathophysiology, and clinical outcomes[J]. Circ Res, 2017, 120(9):1501-1517.
[2] 汤宝鹏. 植入型心电监测仪——让隐匿性心律失常无所遁形[J]. 中华心律失常学杂志, 2018, 22(1):11-13.
[3] Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J, 2016, 37(38):2893-2962.
[4] 董佳佳, 程康安. 亚临床心房颤动的认识与进展[J]. 中国心血管杂志, 2017, 22(5):373-376.
[5] Majos E, Dabrowski R. Significance and management strategies for patients with asymptomatic atrial fibrillation[J]. J Atr Fibrillation, 2015, 7(5):1169.
[6] Lopes RD, Alings M, Connolly SJ, et al. Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in patients with device-detected Sub-clinical Atrial fibrillation(ARTESiA)trial[J]. Am Heart J, 2017, 189:137-145.
[7] 刘力侥, 张晓刚. 亚临床房颤与卒中的研究进展[J]. 重庆医科大学学报, 2018, 43(3):321-325.
[8] 苏晞, 张劲林, 韩宏伟, 等. 单导联心电图记录系统进行心房颤动机会性筛查的首个国内经验[J]. 中华心律失常学杂志, 2017, 21(6):485-488.
[9] Boriani G, Laroche C, Diemberger I, et al. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF pilot general registry[J]. Am J Med, 2015, 128(5):509-518.
[10] Siontis KC, Gersh BJ, Killian JM, et al. Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: characteristics and prognostic implications[J]. Heart Rhythm, 2016, 13(7):1418-1424.
[11] Rienstra M, Vermond RA, Crijns HJ, et al. Asymptomatic persistent atrial fibrillation and outcome: results of the RACE study[J]. Heart Rhythm, 2014, 11(6):939-945.
[12] Glotzer TV, Hellkamp AS, Zimmerman J, et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke-report of the atrial diagnostics ancillary study of the MOde Selection Trial(MOST)[J]. Circulation, 2003, 107(12):1614-1619.
[13] Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke[J]. N Engl J Med, 2012, 366(2):120-129.
[14] Van Gelder IC, Healey JS, Crijns HJ, et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT[J]. Eur Heart J, 2017, 38(17):1339-1344.
[15] Perera KS, Sharma M, Connolly SJ, et al. Stroke type and severity in patients with subclinical atrial fibrillation: an analysis from the asymptomatic atrial fibrillation and stroke evaluation in pacemaker patients and the atrial fibrillation reduction atrial pacing trial(ASSERT)[J]. Am Heart J, 2018, 201:160-163.
[16] Yaghi S, Bernstein RA, Passman R, et al. Cryptogenic stroke research and practice[J]. Circ Res, 2017, 120(3):527-540.
[17] Sposato LA, Cipriano LE, Saposnik G, et al. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis[J]. Lancet Neurol, 2015, 14(4):377-387.
[18] 贺嘉, 方丕华. 亚临床心房颤动与隐源性卒中[J]. 中国心血管杂志, 2015, 20(4):310-312.
[19] Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation[J]. N Engl J Med, 2014, 370(26):2478-2486.
[20] Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke[J]. N Engl J Med, 2014, 370(26):2467-2477.
[21] Choe WC, Passman RS, Brachmann J, et al. A comparison of atrial fibrillation monitoring strategies after cryptogenic stroke(from the cryptogenic stroke and underlying AF trial)[J]. Am J Cardiol, 2015, 116(6):889-893.
[22] 黄从新, 张澍, 黄德嘉, 等. 心房颤动:目前的认识和治疗建议(2018)[J]. 中国心脏起搏与心电生理杂志, 2015, 22(5):377-434.
[23] Chen XL, Ren XJ, Liang Z, et al. Analyses of risk factors and prognosis for new-onset atrial fibrillation in elderly patients after dual-chamber pacemaker implantation[J]. J Geriatr Cardiol, 2018, 15(10):628-633.
[24] Nielsen JC, Thomsen PE, Hojberg SA, et al. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome[J]. Eur Heart J, 2011, 32(6):686-696.
[25] Kaufman ES, Israel CW, Nair GM, et al. Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT[J]. Heart Rhythm, 2012, 9(8):1241-1246.
[26] Aronsson M, Svennberg E, Rosenqvist MA, et al. Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis[J]. Europace, 2017, 19(10):1650-1656.
[27] Moran PS, Teljeur C, Ryan M, et al. Systematic screening for the detection of atrial fibrillation[J]. Cochrane Database Syst Rev, 2016,(6):CD009586.
[28] Welton NJ, Mcaleenan A, Thom HH, et al. Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis[J]. Health Technol Assess, 2017, 21(29):1-236.
[29] Jonas DE, Kahwati LC, Yun JD, et al. Screening for atrial fibrillation with electrocardiography evidence report and systematic review for the US preventive services task force[J]. JAMA, 2018, 320(5):485-498.
[30] Freedman B, Camm J, Calkins H, et al. Screening for atrial fibrillation a report of the AF-SCREEN international collaboration[J]. Circulation, 2017, 135(19):1851-1867.
[31] Mairesse GH, Moran P, Van Gelder IC, et al. Screening for atrial fibrillation: a European Heart Rhythm Association(EHRA)consensus document endorsed by the Heart Rhythm Society(HRS), Asia Pacific Heart Rhythm Society(APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología(SOLAECE)[J]. Europace, 2017, 19(10):1589-1623.
[32] Curry SJ, Krist AH, Owens DK, et al. Screening for atrial fibrillation with electrocardiography US preventive services task force recommendation statement[J]. JAMA, 2018, 320(5):478-484.
[33] Chan NY, Choy CC. Screening for atrial fibrillation in 13 122 Hong Kong citizens with smartphone electrocardiogram[J]. Heart, 2017, 103(1):24-31.
[34] Lowres N, Neubeck L, Salkeld G, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study[J]. Thromb Haemost, 2014, 111(6):1167-1176.
[35] Halcox JP, Wareham K, Cardew AA, et al. Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study[J]. Circulation, 2017, 136(19):1784-1794.
[36] Hindricks G, Pokushalov E, Urban L, et al. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation results of the XPECT trial[J]. Circ Arrhythm Electrophysiol, 2010, 3(2):141-147.
[37] Sanders P, Pürerfellner H, Pokushalov E, et al. Performance of a new atrial fibrillation detection algorithm in a miniaturized insertable cardiac monitor: results from the reveal LINQ usability study[J]. Heart Rhythm, 2016, 13(7):1425-1430.
[38] Wiesel J, Salomone TJ. Screening for atrial fibrillation in patients ≥65 years using an automatic blood pressure monitor in a skilled nursing facility[J]. Am J Cardiol, 2017, 120(8):1322-1324.
[39] Verberk WJ, Omboni S, Kollias AA. Screening for atrial fibrillation with automated blood pressure measurement: research evidence and practice recommendations[J]. Int J Cardiol, 2016, 203:465-473.
[40] Nemati S, Ghassemi MM, Ambai V, et al. Monitoring and detecting atrial fibrillation using wearable technology[J]. Conf Proc IEEE Eng Med Biol Soc, 2016, 2016:3394-3397.
[41] Lown M, Yue A, Lewith G, et al. Screening for Atrial Fibrillation using Economical and accurate TechnologY(SAFETY)-a pilot study[J]. BMJ Open, 2017, 7(1):e013535.
[42] Feigin VL, Nguyen G, Cercy K, et al. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016[J]. N Engl J Med, 2018, 379(25):2429-2437.

备注/Memo

备注/Memo:
基金项目:国家重点研发计划(2016YFC0900905); 国家自然科学基金(81660053,81660071)
通信作者:汤宝鹏,Email:tangbaopeng1111@163.com
更新日期/Last Update: 2019-05-27